Fate Therapeutics Inc (NASDAQ:FATE)

37.18
Delayed Data
As of Jan 21
 -1.12 / -2.92%
Today’s Change
37.05
Today|||52-Week Range
118.14
-36.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash64.8M88.6M89.0M190.5M
 
 
 
 
 
Short Term Investment Cash15.7M23.8M343.0K101.7M
 
 
 
 
 
Cash & Short Term Investments64.8M92.1M100.9M201.0M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.00500.0K
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets843.0K1.2M1.6M3.7M
 
 
 
 
 
Current Assets65.7M93.3M102.6M205.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.6M5.8M7.7M11.5M
 
 
 
 
 
Depreciation-3.5M-4.2M-5.1M-6.3M
 
 
 
 
 
Other Assets24.0K24.0K24.0K526.0K
 
 
 
 
 
Total Assets68.0M95.0M105.3M213.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.00934.0K1.7M4.2M
 
 
 
 
Short Term Debt7.6M8.2M0.002.4M
 
 
 
 
Accrued Expenses1.5M2.5M5.5M8.0M
 
 
 
 
 
Other Current Liabilities4.9M4.6M7.6M17.7M
 
 
 
 
 
Other Liabilities13.4M15.2M11.0M27.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt10.7M2.5M14.8M12.4M
 
 
 
 
 
Other Liabilities857.0K1.4M1.5M5.4M
 
 
 
 
 
Total Liabilities29.9M21.9M28.1M52.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.003.0K3.0K3.0K
 
 
 
 
Common Equity38.0M73.2M77.2M160.5M
 
 
 
 
 
Total Shareholder Equity38.0M73.2M77.2M160.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding28.7M41.4M52.6M64.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.